Medline Inc (MDLN)

Currency in USD
47.93
+0.26(+0.55%)
Closed·
47.930.00(0.00%)
·
MDLN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
47.5448.17
52 wk Range
34.8950.88
Key Statistics
Prev. Close
47.67
Open
47.54
Day's Range
47.54-48.17
52 wk Range
34.89-50.88
Volume
4.5M
Average Vol. (3m)
5.52M
1-Year Change
-
Book Value / Share
12.9
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MDLN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
53.52
Upside
+11.66%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Medline Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon’s gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Medline Inc Earnings Call Summary for Q4/2025

  • Q4 net sales surged 15% YoY to $7.8B, but adjusted EBITDA flat at $805M with margins down 160 bps; stock fell 2.91% to $47.11 pre-market
  • Full-year 2025 free cash flow reached $1.3B; capex of $447M directed toward automation investments and distribution center expansion
  • Tariff mitigation delivered $35M favorable variance in 2025, but company faces projected $200M incremental tariff headwinds in 2026
  • FY2026 guidance projects revenue of $30.57B and EPS of $2.38, supported by continued investments in automation and product innovation
  • Stock trades at elevated P/E of 558x with $67.3B market cap; InvestingPro rates financial health as 'GREAT' despite overvaluation concerns
Last Updated: 02/25/2026, 10:46 AM
Read Full Transcript

Compare MDLN to Peers and Sector

Metrics to compare
MDLN
Peers
Sector
Relationship
P/E Ratio
33.6x5.1x−0.5x
PEG Ratio
0.02−0.050.00
Price / Book
5.9x2.9x2.6x
Price / LTM Sales
2.2x1.9x3.2x
Upside (Analyst Target)
15.0%49.3%45.7%
Fair Value Upside
Unlock16.8%4.8%Unlock

Analyst Ratings

23 Buy
5 Hold
0 Sell
Ratings:
28 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 53.52
(+11.66% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Buy57.00+18.92%56.00MaintainMar 19, 2026
Citi
Buy60.00+25.18%-New CoverageMar 11, 2026
JPMorgan
Buy53.00+10.58%50.00MaintainMar 10, 2026
Tigress Financial Partners
Buy60.00+25.18%-MaintainMar 09, 2026
BTIG
Buy55.00+14.75%-MaintainMar 09, 2026

Earnings

Latest Release
Feb 25, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
7.79B / --
EPS Revisions
Last 90 days

MDLN Income Statement

People Also Watch

34.410
PL
+1.41%
824.01
LITE
-3.37%
198.42
AVAV
+2.00%
985.92
GEV
-0.16%
118.69
CRWV
+1.27%

FAQ

What Is the Medline (MDLN) Stock Price Today?

The Medline stock price today is 47.93 USD.

What Stock Exchange Does Medline Trade On?

Medline is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Medline?

The stock symbol for Medline is "MDLN."

What Is the Medline Market Cap?

As of today, Medline market cap is 62.62B USD.

What Is Medline's Earnings Per Share (TTM)?

The Medline EPS (TTM) is 1.43.

When Is the Next Medline Earnings Date?

Medline will release its next earnings report on May 06, 2026.

From a Technical Analysis Perspective, Is MDLN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Medline Stock Split?

Medline has split 0 times.

How Many Employees Does Medline Have?

Medline has 45000 employees.

What is the current trading status of Medline (MDLN)?

As of Apr 16, 2026, Medline (MDLN) is trading at a price of 47.93 USD, with a previous close of 47.67 USD. The stock has fluctuated within a day range of 47.54 USD to 48.17 USD, while its 52-week range spans from 34.89 USD to 50.88 USD.

What Is Medline (MDLN) Price Target According to Analysts?

The average 12-month price target for Medline is 53.52 USD, with a high estimate of 60 USD and a low estimate of 45 USD. 23 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +11.66% Upside potential.

What Is the MDLN Premarket Price?

MDLN's last pre-market stock price is 47.76 USD. The pre-market share volume is 600.00, and the stock has decreased by 0.09, or 0.19%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.